Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 1979757
PUBLISHER: GlobalData | PRODUCT CODE: 1979757
Germany Neuromodulation Devices Market Outlook to 2033 - Implantable Neuromodulation Devices and Non-Invasive Neuromodulation Devices
PUBLISHED:
PAGES: 43 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
GlobalData's "Germany Neuromodulation Devices Outlook to 2033" is a comprehensive databook report, covering key market data on the Germany Neuromodulation Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Implantable Neuromodulation Devices, Minimally Invasive Neuromodulation Devices and Non-Invasive Neuromodulation Devices
The Germany Neuromodulation Devices Market report provides key information and data on -
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
- 2025 company share data for Neuromodulation Devices Market.
- Global corporate-level profiles of key companies operating within the Germany Neuromodulation Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
Germany Neuromodulation Devices is segmented as follows -
- Implantable Neuromodulation Devices
- Minimally Invasive Neuromodulation Devices
- Non-Invasive Neuromodulation Devices
Reasons to Buy
The Germany Neuromodulation Devices Market report helps you to develop -
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Product Code: GDME47182CCDB
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 What Is This Report About?
- 2.2 Neuromodulation Devices Market Segmentation
- 2.3 Definitions of Markets Covered in the Report
3 Neuromodulation Devices Market, Germany
- 3.1 Neuromodulation Devices Market, Germany, Revenue ($m), 2018-2033
- 3.1.1 Implantable Neuromodulation Devices Market, Germany, Revenue ($m), by Segment, 2018-2033
- 3.2 Neuromodulation Devices Market, Germany, Volume (Units), 2018-2033
- 3.2.1 Implantable Neuromodulation Devices Market, Germany, Volume (Units), by Segment, 2018-2033
- 3.3 Neuromodulation Devices Market, Germany, Average Price ($), 2018-2033
- 3.4 Neuromodulation Devices Market, Germany, Company Share by Revenue ($m), 2025
4 Overview of Key Companies in Germany, Neuromodulation Devices Market
- 4.1 Medtronic Plc
- 4.1.1 Company Overview
- 4.2 Boston Scientific Corp
- 4.2.1 Company Overview
- 4.3 Abbott Laboratories
- 4.3.1 Company Overview
- 4.4 LivaNova Plc
- 4.4.1 Company Overview
- 4.5 Nevro Corp
- 4.5.1 Company Overview
- 4.6 Enterra Medical Inc
- 4.6.1 Company Overview
- 4.7 Axonics Inc
- 4.7.1 Company Overview
- 4.8 B. Braun Melsungen AG
- 4.8.1 Company Overview
- 4.9 Bioness Inc
- 4.9.1 Company Overview
- 4.10 Xavant Technology (Pty) Ltd
- 4.10.1 Company Overview
5 Neuromodulation Devices Market Pipeline Products
6 Recent Developments
- 6.1 Corporate Communications
- 6.1.1 Nov 11, 2025: Novel Technique Enhances Brain-State Detection
- 6.1.2 Sep 08, 2025: Changes To The Executive Board Of Carl Zeiss AG
- 6.1.3 Mar 25, 2025: CorTec Names Frank Desiere as Chief Executive Officer
- 6.2 Product News
- 6.2.1 Oct 31, 2025: European Investment Bank Supports German MedTech with €20 Million for PRECISIS
- 6.2.2 Oct 16, 2025: First Brain-Computer Interface Implantation for Paralysis in Europe
- 6.2.3 Sep 10, 2025: Neurocare Group's Apollo TMS Therapy Devices Granted FDA Clearance for Treating Adolescent Depression
- 6.2.4 Sep 08, 2025: Onward Medical Receives CE Mark for Arc-Ex, Enabling Commercial Launch in Europe
- 6.3 Strategy And Business Planning
- 6.3.1 Nov 04, 2025: Zeiss Opens New Quality Excellence Center in Connecticut
- 6.3.2 Oct 31, 2025: European Investment Bank Supports German MedTech with €20 Million for PRECISIS
7 Appendix
- 7.1 Research Methodology
- 7.1.1 Coverage
- 7.1.2 Secondary Research
- 7.1.3 Primary Research
- 7.1.4 Market Modeling and Forecasting
- 7.1.5 Company Share Analysis
- 7.1.6 Benchmarking
- 7.2 GlobalData Consulting
- 7.3 Contact Us
- 7.4 Disclaimer
Product Code: GDME47182CCDB
List of Table
List of Tables
- Table 1: Neuromodulation Devices Market, Germany, Revenue ($m), USD Constant, 2018-2033
- Table 2: Implantable Neuromodulation Devices Market, Germany, Revenue ($m), USD Constant, 2018-2033
- Table 3: Neuromodulation Devices Market, Germany, Volume (Units), 2018-2033
- Table 4: Implantable Neuromodulation Devices Market, Germany, Volume (Units), 2018-2033
- Table 5: Neuromodulation Devices Market, Germany, Average Price ($), 2018-2033
- Table 6: Neuromodulation Devices Market, Germany, Company Share by Revenue ($m), 2025
- Table 7: Neuromodulation Devices Market Pipeline Products
- Table 8: Total Number of Primary Research Participants, Neurology Devices Market, by Country
List of Figure
List of Figures
- Figure 1: Neuromodulation Devices Market, Germany, Revenue ($m), USD Constant, 2018-2033
- Figure 2: Implantable Neuromodulation Devices Market, Germany, Revenue ($m), USD Constant, 2018-2033
- Figure 3: Neuromodulation Devices Market, Germany, Volume (Units), 2018-2033
- Figure 4: Implantable Neuromodulation Devices Market, Germany, Volume (Units), 2018-2033
- Figure 5: Neuromodulation Devices Market, Germany, Company Share (%), 2025
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.